MORTALITY RATES FROM ACUTE CORONARY SYNDROME IN OCTOGENARIAN PATIENTS IN ISRAEL DURING THE PERIOD 2000-2006 COMPARED TO 2008-2013  by Shechter, Michael et al.
A78
JACC March 17, 2015
Volume 65, Issue 10S
Acute Coronary Syndromes
moRtality Rates FRom acute coRonaRy syndRome in octogenaRian patients in isRael 
duRing the peRiod 2000-2006 compaRed to 2008-2013
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Insights from Subgroups: Age, Gender and Diabetes
Abstract Category: 2. Acute Coronary Syndromes: Clinical
Presentation Number: 1138-057
Authors: Michael Shechter, Ilan Goldenberg, Shlomi Matetzky, ASCIS investigators ASCIS, Leviev Heart Center, Chaim Sheba Medical 
Center, Tel Hashomer, Israel, The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
background:  Few data are available regarding the outcome of octogenarians with acute coronary syndrome (ACS).
methods:  We evaluated 30-day and 1-year clinical outcome of 1477 patients ≥ 80 years old (mean age 85±4, females 43%) from the 
Acute Coronary Syndrome Israel Survey (ACSIS), by analyzing data from ACS patients hospitalized in all coronary care units in Israel 
during two-month periods/year during the period 2000 to 2006 (“early period”, n=1033) and compared to the period of 2008 to 2013 (“late 
period”, n=444).
Results:  In the late compared to the early period octogenarian patients were older (85±4 vs 84±4 years; p<0.01), had more prior 
myocardial infarctions (MI) (41% vs 36%, p<0.02), percutaneous coronary interventions (PCI) (37% vs 16%, p<0.01) and prior chronic renal 
disease (30% vs 24%, p<0.01). Time from chest pain to hospitalization and PCI were similar in both groups. Significantly more patients in 
the late period underwent PCI compared to the early period (94% vs 55%, p<0.01), received more dual antiplatelet therapy (84% vs 42%, 
p<0.01), beta blockers (80% vs 67%, p<0.01), angiotensin-converting enzyme inhibitors (74% vs 69%, p<0.02) and statins (91% vs 53%, 
p<0.01). Mean hospital duration was significantly higher in patients from early compared to the late period (8±7 vs 7±6 days, p<0.01). In-
hospital, 7-day-, 30-day- and 1-year mortality rate were significantly higher in ACS octogenerains from the early compared to the late period 
(12% vs 8%, p<0.02; 11% vs 8%, p<0.05; 17% vs 14%, p<0.07; 32% vs 27%, p<0.05; respectively). Major adverse CV events (30-day 
mortality, hospitalization for unstable angina, MI) were also significantly more frequent in those from the early compared to the late group 
(31% vs 21%, p<0.01). Multivariate Cox regression analysis demonstrated better 1-year survival in octogenarians with ACS from the late 
compared to the early period with HR 1.17, 95% CI 0.87 to 1.57 (p=0.03).
conclusion:  In-hospital, 30-day and 1-year survival rates of ACS octogenarian patients in Israel during the period 2008 to 2013 
significantly improved compared to those in the earlier period between year 2000 to 2006.
